Cellectis S.A. | Mid-cap | Healthcare
€2.37
-2.47%
| Cellectis S.A Stock Comparison:
Cellectis S.A vs Abivax SACellectis S.A vs Valneva SECellectis S.A vs Medincell S.ACellectis S.A vs BNP Paribas EasyCellectis S.A vs Inventiva S.ACellectis S.A vs CAC 40 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 10.7M
Gross Profit 8.6M 81.09%
Operating Income -14.2M -133.07%
Net Income -18.1M -170.14%
EPS (Diluted) €-0.18

Balance Sheet Metrics

Total Assets 364.1M
Total Liabilities 247.9M
Shareholders Equity 116.2M
Debt to Equity 2.13

Cash Flow Metrics

Operating Cash Flow -18.6M
Free Cash Flow -17.6M

Revenue & Profitability Trend

Cellectis S.A Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i41.5M755.0K19.2M30.3M51.1M
Cost of Goods Sold i9.2M737.0K1.8M1.8M2.0M
Gross Profit i32.3M18.0K17.4M28.5M49.1M
Gross Margin % i77.9%2.4%90.8%93.9%96.2%
Operating Expenses
Research & Development i90.5M87.6M97.5M117.8M77.0M
Selling, General & Administrative i8.4M16.8M17.5M22.9M22.5M
Other Operating Expenses i-8.6M-556.0K-1.4M-499.0K289.0K
Total Operating Expenses i90.4M103.9M113.6M140.2M99.9M
Operating Income i-59.6M-97.3M-89.7M-103.5M-42.3M
Operating Margin % i-143.5%-12,887.7%-467.7%-341.0%-82.9%
Non-Operating Items
Interest Income i11.3M3.6M1.1M719.0K1.4M
Interest Expense i7.5M5.3M3.8M4.2M2.4M
Other Non-Operating Income19.0M-16.4M6.1M9.7M-10.6M
Pre-tax Income i-36.8M-116.5M-98.6M-96.8M-53.6M
Income Tax i0371.0K87.0K00
Effective Tax Rate % i0.0%0.0%0.0%0.0%0.0%
Net Income i-36.8M-108.4M-114.0M-125.1M-97.5M
Net Margin % i-88.6%-14,363.3%-594.8%-412.3%-190.9%
Key Metrics
EBITDA i-28.4M-76.3M-82.4M-88.2M-32.8M
EPS (Basic) i€-0.41€-1.77€-2.33€-1.91€-1.91
EPS (Diluted) i€-0.41€-1.77€-2.33€-1.91€-1.91
Basic Shares Outstanding i9056634662283535467734984358419343642029
Diluted Shares Outstanding i9056634662283535467734984358419343642029

Income Statement Trend

Cellectis S.A Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i143.3M136.7M89.8M185.6M241.1M
Short-term Investments i117.1M67.1M7.9M499.0K27.1M
Accounts Receivable i6.7M569.0K772.0K20.4M5.2M
Inventory i--001.6M
Other Current Assets298.0K345.0K538.0K50.0K12.2M
Total Current Assets i287.1M233.0M143.8M225.4M315.4M
Non-Current Assets
Property, Plant & Equipment i92.9M91.5M90.6M95.2M28.9M
Goodwill i1.1M672.0K718.0K1.9M1.6M
Intangible Assets i1.1M672.0K718.0K1.9M1.6M
Long-term Investments-----
Other Non-Current Assets12.0M-1.0K-3.0K-1.0K
Total Non-Current Assets i96.5M101.3M117.4M156.6M154.1M
Total Assets i383.5M334.3M261.2M382.1M469.5M
Liabilities
Current Liabilities
Accounts Payable i18.7M19.1M21.5M23.8M24.6M
Short-term Debt i13.2M13.7M12.8M10.6M6.7M
Current Portion of Long-term Debt-----
Other Current Liabilities12.5M978.0K15.7M1.3M6.1M
Total Current Liabilities i166.3M155.1M63.0M49.3M52.0M
Non-Current Liabilities
Long-term Debt i78.2M71.4M62.9M90.3M100.0M
Deferred Tax Liabilities i0158.0K---
Other Non-Current Liabilities882.0K12.9M7.0M1.9M4.6M
Total Non-Current Liabilities i86.2M94.4M72.3M96.3M108.6M
Total Liabilities i252.5M249.6M135.3M145.6M160.6M
Equity
Common Stock i5.9M4.4M3.0M2.9M2.8M
Retained Earnings i-329.6M-405.8M-439.5M-698.3M-587.0M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i131.0M84.7M125.9M236.5M308.8M
Key Metrics
Total Debt i91.5M85.1M75.8M100.9M106.7M
Working Capital i120.8M77.9M80.8M176.1M263.3M

Balance Sheet Composition

Cellectis S.A Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i-36.8M-116.8M-98.7M-96.7M-53.6M
Depreciation & Amortization i19.8M18.5M18.4M14.2M7.8M
Stock-Based Compensation i3.2M5.2M6.0M11.5M10.0M
Working Capital Changes i53.7M48.9M-5.7M-12.3M-17.3M
Operating Cash Flow i18.6M-26.1M-71.2M-89.9M-39.3M
Investing Activities
Capital Expenditures i-2.6M-1.1M-2.4M-18.5M-44.1M
Acquisitions i-----
Investment Purchases i-162.8M---143.0K-2.1M
Investment Sales i63.8M-126.0K15.0M5.0M
Investing Cash Flow i-101.5M-2.7M-2.3M-3.7M-41.2M
Financing Activities
Share Repurchases i---569.0K--
Dividends Paid i00000
Debt Issuance i23.2M29.7M5.8M024.2M
Debt Repayment i-16.1M-16.2M-12.4M-10.6M-4.7M
Financing Cash Flow i90.0M81.4M-7.2M34.0M28.6M
Free Cash Flow i19.1M-25.8M-89.9M-123.1M-124.7M
Net Change in Cash i7.0M52.6M-80.7M-59.6M-51.8M

Cash Flow Trend

Cellectis S.A Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -5.88
Forward P/E -2.68
Price to Book 2.45
Price to Sales 3.84
PEG Ratio -2.68

Profitability Ratios

Profit Margin -93.00%
Operating Margin -52.69%
Return on Equity -48.02%
Return on Assets -7.43%

Financial Health

Current Ratio 1.38
Debt to Equity 40.92

Per Share Data

EPS (TTM) €-0.51
Book Value per Share €0.98
Revenue per Share €0.64

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
alcls243.9M-5.882.45-48.02%-93.00%40.92
Abivax SA 4.5B-22.33-597.06-196.12%0.00%-16.16
Valneva SE 546.9M70.642.82-44.11%-43.21%120.48
Medincell S.A 524.6M--112.65%-66.50%-3.59
BNP Paribas Easy 463.1M15.99--96.39%-27.22%2.22
Inventiva S.A 391.5M-0.91-1.02172.73%0.00%-1.70

Financial data is updated regularly. All figures are in the company's reporting currency.